Church & Dwight Co., Inc. (NYSE:CHD) Shares Sold by Wendell David Associates Inc.

Wendell David Associates Inc. cut its holdings in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 0.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 173,665 shares of the company’s stock after selling 1,180 shares during the period. Church & Dwight comprises approximately 1.8% of Wendell David Associates Inc.’s investment portfolio, making the stock its 14th biggest holding. Wendell David Associates Inc.’s holdings in Church & Dwight were worth $18,184,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Capital Performance Advisors LLP purchased a new stake in shares of Church & Dwight in the third quarter worth about $27,000. Ashton Thomas Securities LLC acquired a new position in Church & Dwight in the third quarter valued at approximately $28,000. Versant Capital Management Inc boosted its position in Church & Dwight by 224.4% in the 4th quarter. Versant Capital Management Inc now owns 266 shares of the company’s stock worth $28,000 after purchasing an additional 184 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Church & Dwight during the 2nd quarter worth approximately $33,000. Finally, Kimelman & Baird LLC purchased a new position in shares of Church & Dwight during the 2nd quarter valued at approximately $46,000. 86.60% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Arthur B. Winkleblack sold 11,590 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $103.84, for a total value of $1,203,505.60. Following the sale, the director now directly owns 7,129 shares of the company’s stock, valued at approximately $740,275.36. The trade was a 61.92 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael Read acquired 1,100 shares of the firm’s stock in a transaction dated Monday, December 16th. The stock was bought at an average price of $106.82 per share, for a total transaction of $117,502.00. Following the completion of the acquisition, the executive vice president now owns 2,505 shares in the company, valued at approximately $267,584.10. The trade was a 78.29 % increase in their position. The disclosure for this purchase can be found here. Insiders sold a total of 593,035 shares of company stock valued at $62,282,808 over the last quarter. 2.00% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CHD. Piper Sandler increased their price target on shares of Church & Dwight from $124.00 to $128.00 and gave the stock an “overweight” rating in a report on Monday, January 6th. Stifel Nicolaus dropped their target price on Church & Dwight from $105.00 to $103.00 and set a “hold” rating on the stock in a research report on Friday, January 17th. TD Cowen upped their price target on Church & Dwight from $114.00 to $117.00 and gave the stock a “buy” rating in a report on Monday, November 4th. JPMorgan Chase & Co. raised their price objective on Church & Dwight from $99.00 to $107.00 and gave the company an “underweight” rating in a report on Thursday, January 16th. Finally, Wells Fargo & Company increased their target price on Church & Dwight from $113.00 to $115.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $110.61.

Church & Dwight Stock Down 0.0 %

Shares of NYSE:CHD opened at $106.64 on Thursday. Church & Dwight Co., Inc. has a 52-week low of $96.09 and a 52-week high of $113.50. The stock has a market cap of $26.13 billion, a P/E ratio of 47.82, a PEG ratio of 3.29 and a beta of 0.58. The business has a fifty day moving average of $106.81 and a two-hundred day moving average of $104.05. The company has a quick ratio of 1.09, a current ratio of 1.62 and a debt-to-equity ratio of 0.53.

Church & Dwight (NYSE:CHD) last announced its quarterly earnings data on Friday, November 1st. The company reported $0.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.68 by $0.11. Church & Dwight had a net margin of 9.08% and a return on equity of 19.90%. The firm had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same quarter in the prior year, the firm posted $0.74 earnings per share. Church & Dwight’s quarterly revenue was up 3.8% on a year-over-year basis. On average, research analysts expect that Church & Dwight Co., Inc. will post 3.44 earnings per share for the current year.

Church & Dwight Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 2nd. Investors of record on Friday, November 15th were given a $0.2838 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.14 annualized dividend and a yield of 1.06%. Church & Dwight’s payout ratio is 50.67%.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.